Mixed Tumor, Mullerian 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mixed Tumor, Mullerian
NCT02090127: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

No Longer Available
N/A
US
ficlatuzumab, AV-299, SCH 900105
AVEO Pharmaceuticals, Inc.
Mullerian Mixed Tumor of Ovary
 
 

Download Options